Metoprolol Succinate Tablet, Extended Release
Product Images NDC 50090-6488

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 50090-6488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Figure001)

This text provides information about the results of the MERIT-HF trial, comparing the efficacy of Wetoprolol Succinate extended-release tablets to placebo in reducing total mortality or all-cause hospitalization in patients with heart failure of NYHA II-IV classes, different etiology, ethnicity, and comorbidities. The text includes subgroup analyses based on demographic and clinical characteristics such as gender, race, previous medical history, and heart rate. The data is presented in the form of relative risks and confidence intervals, and EF values.*

FDA Label Image

Label Image (Lbl500906488)

FDA Label Image

Structure (Structure001)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.